earnings
OK
NASDAQ · OKUR
OnKure Therapeutics, Inc.
Healthcare · Biotechnology
$2.93
Down-$0.07 (-2.33%)
Updated Sep 16, 2026, 12:51 PM
SID Score
3.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 44.44M
- P/E ratio
- -6.67
- Dividend yield
- 0.00%
- 52-week range
- $2.23 – $5.38
- Volume
- 171.1K
- Avg. volume
- 131.89K
Price performance
OKUR price history
1M range · 20 trading sessions · Daily adjusted prices
OKUR closed at $2.93 after 20 trading sessions, down 30.40% for the selected period.
- Last close
- $2.93
- Period change
- -30.40%
- Period low
- $2.93
- Period high
- $4.21
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $2.98 | $2.98 | $2.815 | $2.93 | 171.1K |
| Sep 14, 2026 | $3.11 | $3.14 | $2.978 | $3.00 | 105.16K |
| Sep 11, 2026 | $3.31 | $3.33 | $2.98 | $3.10 | 253.65K |
| Sep 10, 2026 | $3.36 | $3.42 | $3.24 | $3.27 | 168.52K |
| Sep 9, 2026 | $3.38 | $3.4899 | $3.319 | $3.38 | 80.09K |
| Sep 8, 2026 | $3.55 | $3.90 | $3.34 | $3.40 | 115.01K |
| Sep 4, 2026 | $3.53 | $3.62 | $3.5075 | $3.58 | 165.54K |
| Sep 3, 2026 | $3.56 | $3.62 | $3.52 | $3.56 | 132.19K |
| Sep 2, 2026 | $3.54 | $3.665 | $3.41 | $3.54 | 127.42K |
| Sep 1, 2026 | $3.62 | $3.70 | $3.4935 | $3.56 | 193.56K |
| Aug 31, 2026 | $3.80 | $3.8999 | $3.54 | $3.63 | 100.48K |
| Aug 28, 2026 | $3.83 | $4.02 | $3.67 | $3.79 | 432.47K |
| Aug 27, 2026 | $3.77 | $3.86 | $3.77 | $3.83 | 97.73K |
| Aug 26, 2026 | $3.86 | $4.0126 | $3.70 | $3.80 | 80.36K |
| Aug 25, 2026 | $3.91 | $4.043 | $3.79 | $3.85 | 116.23K |
| Aug 24, 2026 | $3.95 | $4.39 | $3.70 | $3.89 | 421.07K |
| Aug 21, 2026 | $3.95 | $4.0728 | $3.90 | $3.94 | 59.91K |
| Aug 20, 2026 | $4.04 | $4.043 | $3.78 | $3.93 | 103.52K |
| Aug 19, 2026 | $4.29 | $4.42 | $4.07 | $4.08 | 166.17K |
| Aug 18, 2026 | $4.11 | $4.27 | $3.99 | $4.21 | 108.17K |
Latest OKUR news
The latest Smart Investors Daily articles mentioning OKUR.
Stock researchCompany · Dividend
Loading stock research…

